Friday, July 04, 2025 | 09:29 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Glaxosmithkline Pharmaceuticals Share Price

Know More
BSENSE

2,682.35 157.35 (6.23%)

04:01 PM, 12-Mar-2025
Stock not traded

BSE : 500660

NSE : GLAXO

Sector : Health care

ISIN Code : INE159A01016

  • BSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: 12-Mar-2025 | 04:01 PM IST

Market Cap (₹ Cr)

45,442

Traded Value (₹ Cr)

2.53

Volume (Shares)

9,430

Face Value (₹)

10

52-Week High (₹)

3,087.95

52-Week High Date

22-Aug-2024

52-Week Low (₹)

1,825.05

52-Week Low Date

15-Apr-2024

All Time High (₹)

3,087.95

All Time High Date

22-Aug-2024

All Time Low (₹)

12.88

All Time Low Date

19-Aug-1988

Glaxosmithkline Pharmaceuticals Ltd

GlaxoSmithKline Pharmaceuticals Limited is one of the leading pharmaceutical companies in the India. It is a subsidiary of GlaxoSmithKline plc UK one of the world's leading research-based pharmaceutical and healthcare companies. The Company is engaged interalia in the business of manufacturing distributing and trading in pharmaceuticals.The Company...
Read More
BSE

Glaxosmithkline Pharmaceuticals Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr)

45,442

EPS - TTM (₹) [C]

50.42

P/E Ratio (X) [C]

53.20

Face Value (₹) 10
Latest Dividend (%)120.00
Latest Dividend Date 07-Nov-2024
Dividend Yield (%) 1.19
Book Value Share (₹) [C]98.74
P/B Ratio (₹) [C]27.17

Funds Owning this Stock

Scheme Name Amount Invested (₹ Cr) No Of Shares Net Asset (%)
SBI Magnum Midcap Fund (G) 419.89 16,96,276 2.17
SBI Magnum Midcap Fund (IDCW) 419.89 16,96,276 2.17
SBI Magnum Midcap Fund - Direct (G) 419.89 16,96,276 2.17
SBI Magnum Midcap Fund - Direct (IDCW) 419.89 16,96,276 2.17
Kotak Equity Opportunities (G) 272.29 11,00,000 1.19
Kotak Equity Opportunities - Direct (G) 272.29 11,00,000 1.19
Aditya Birla SL ELSS Tax Saver Fund (IDCW) 233.01 9,41,321 1.71
Aditya Birla SL ELSS Tax Saver Fund (G) 233.01 9,41,321 1.71
Aditya Birla SL ELSS Tax Saver Fund - Direct (IDCW) 233.01 9,41,321 1.71
Aditya Birla SL ELSS Tax Saver Fund - Direct (G) 233.01 9,41,321 1.71

Load more

Research Reports

DateBrokerActionPrices(₹) Report
Data Not Found

Stock Strength

Today's Low/High (₹)

2,653.10

2,743.95

Week Low/High (₹)

1,230.70

2,743.95

Month Low/High (₹)

1,230.70

2,743.95

Year Low/High (₹)

1,825.05

3,088.00

All time Low/High (₹)

12.88

3,088.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week112.61%112.44%22.97%27.64%
1 Month105.74%105.78%19.03%23.24%
3 Month97.03%97.11%19.93%24.47%
6 Month93.81%94.06%25.04%29.23%
1 Year72.84%73.13%24.11%27.96%
3 Year62.81%62.97%82.98%91.93%

Company Info

Company Information

Independent Director : D Sundaram

Company Sec. & Compli. Officer : A A Nadkarni

Independent Director : P V Bhide

Independent Director : A N Roy

Non Executive Director : Subesh Williams

Chairperson : Renu S Karnad

Independent Director : Sunita Maheshwari

Independent Director : Manu Anand

Managing Director : Bhushan Akshikar

Whole Time Director & CFO : J. Chandy

Registered Office: GSK House, Dr Annie Besant Road Worli,Mumbai,Maharashtra-400030 Ph: 91-022-24959595

Email:askus@gsk.com; ajay.a.nadkarni@gsk.com

URL:http://www.gsk-india.com

FAQs about Glaxosmithkline Pharmaceuticals Ltd

1. What's the Glaxosmithkline Pharmaceuticals Ltd share price today?
Glaxosmithkline Pharmaceuticals Ltd share price was Rs 2,682.35 at 04:01 PM IST on 12th Mar 2025. Glaxosmithkline Pharmaceuticals Ltd share price was up by 6.23% over the previous closing price of Rs 2,525.00. Glaxosmithkline Pharmaceuticals Ltd share price trend:

  • Last 1 Month: Glaxosmithkline Pharmaceuticals Ltd share price moved up by 105.74% on BSE.
  • Last 3 Months: Glaxosmithkline Pharmaceuticals Ltd share price moved up by 97.03% on BSE.
  • Last 12 Months: Glaxosmithkline Pharmaceuticals Ltd share price moved up by 72.84% on BSE.
  • Last 3 Years: Glaxosmithkline Pharmaceuticals Ltd share price moved up by 62.81% on BSE.


2. How can I quickly analyse the performance of the Glaxosmithkline Pharmaceuticals Ltd stock?
The performance of the Glaxosmithkline Pharmaceuticals Ltd stock can be quickly analysed on the following metrics:

  • The stock's PE is 53.20
  • Price to book value ratio is 27.17
  • Dividend yield of 1.19
  • The EPS (trailing 12 months) of the Glaxosmithkline Pharmaceuticals Ltd stock is Rs 50.42


3. What is the market cap of Glaxosmithkline Pharmaceuticals Ltd?
Glaxosmithkline Pharmaceuticals Ltd has a market capitalisation of Rs 45,442 crore.


4. What is Glaxosmithkline Pharmaceuticals Ltd's 52-week high/low share price?
The Glaxosmithkline Pharmaceuticals Ltd’s 52-week high share price is Rs 3,087.95 and 52-week low share price is Rs 1,825.05.


5. Is the Glaxosmithkline Pharmaceuticals Ltd profitable?
On a consolidated basis, Glaxosmithkline Pharmaceuticals Ltd reported a profit of Rs 229.88 crore on a total income of Rs 984.49 crore for the quarter ended 2024. For the year ended 2024, Glaxosmithkline Pharmaceuticals Ltd had posted a profit of Rs 589.96 crore on a total income of Rs 3,453.71 crore.


6. Which are Glaxosmithkline Pharmaceuticals Ltd’s peers in the Health care sector?
Glaxosmithkline Pharmaceuticals Ltd’s top 5 peers in the Health care sector are Aurobindo Pharma, Abbott India, Alkem Lab, Glaxosmi. Pharma, Glenmark Pharma., Biocon, Ipca Labs..


7. Who owns how much in Glaxosmithkline Pharmaceuticals Ltd?
Key changes to the Glaxosmithkline Pharmaceuticals Ltd shareholding are as follows:

  • Promoter holding in Glaxosmithkline Pharmaceuticals Ltd has gone up to 75.00 per cent as of Dec 2022 from 75.00 per cent as of Mar 2022.